• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】49426

【品名】(2S)-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid

【CA登记号】

【 分 子 式 】C10H19NO3Si

【 分 子 量 】229.3513

【元素组成】C 52.37% H 8.35% N 6.11% O 20.93% Si 12.25%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(I)

The condensation of N-(tert-butyldimethylsilyl)-4-oxoazetidine-2(S)-carboxylic acid (I) with 1-chloro-3-iodopropane (II) by means of BuLi and triisopropylamine (TIA) in THF, followed by treatment with HCl, gives the 3(R)-(3-chloropropyl) derivative (III), which is treated with tetrabutylammonium azide and tetrabutylammonium iodide in DMF to yield the 3-azidopropyl derivative (IV). The reduction of (IV) with H2 over Pd/C in DMF affords the 3-aminopropyl compound (V), which is treated with 1-[N,N'-bis(benzyloxycarbonyl)-1H-pyrazole] (VI) in the same solvent to provide the protected 3-guanidinopropyl compound (VII). The esterification of (VII) with NaHCO3, tetrabutylammonium iodide and Bn-Br in DMF gives the benzyl ester (VIII), which is condensed with N-tert-butylpiperazine-1-carboxamide (IX) and phosgene by means of TEA in toluene to yield the protected precursor (X). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in dioxane to give the target azetidine-carboxylic acid.

1 Treuner, U.; Kronenthal, D.R.; Xu, Z.; Seiler, S.; Slusarchyk, W.A.; Bisacchi, G.; Randazzo, M.E.; Sutton, J.C.; Shi, Z.; Zahler, R.; Schwinden, M.D. (Bristol-Myers Squibb Co.); Amidino and guanidino azetidinone tryptase inhibitors. WO 9967215 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49426 (2S)-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid C10H19NO3Si 详情 详情
(II) 49416 1-Chloro-3-iodopropane 6940-76-7 C3H6ClI 详情 详情
(III) 49417 (2S,3R)-3-(3-chloropropyl)-4-oxo-2-azetidinecarboxylic acid C7H10ClNO3 详情 详情
(IV) 49418 (2S,3R)-3-(3-azidopropyl)-4-oxo-2-azetidinecarboxylic acid C7H10N4O3 详情 详情
(V) 49419 (2S,3R)-3-(3-aminopropyl)-4-oxo-2-azetidinecarboxylic acid C7H12N2O3 详情 详情
(VI) 49420 benzyl (E)-[[(benzyloxy)carbonyl]amino](1H-pyrazol-1-yl)methylidenecarbamate C20H18N4O4 详情 详情
(VII) 49421 (2S,3R)-3-[3-[([[(benzyloxy)carbonyl]amino][[(benzyloxy)carbonyl]imino]methyl)amino]propyl]-4-oxo-2-azetidinecarboxylic acid C24H26N4O7 详情 详情
(VIII) 49422 benzyl (2S,3R)-3-[3-[([[(benzyloxy)carbonyl]amino][[(benzyloxy)carbonyl]imino]methyl)amino]propyl]-4-oxo-2-azetidinecarboxylate C31H32N4O7 详情 详情
(IX) 49423 N-(tert-butyl)-1-piperazinecarboxamide C9H19N3O 详情 详情
(X) 49424 benzyl (2S,3R)-3-[3-[([[(benzyloxy)carbonyl]amino][[(benzyloxy)carbonyl]imino]methyl)amino]propyl]-1-([4-[(tert-butylamino)carbonyl]-1-piperazinyl]carbonyl)-4-oxo-2-azetidinecarboxylate C41H49N7O9 详情 详情
(XI) 13225 N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate 143238-38-4 C9H18N2O2 详情 详情
(XII) 16976 tert-butylisocyanate; tert-butyl isocyanate; 2-isocyanato-2-methylpropane 1609-86-5 C5H9NO 详情 详情
(XIII) 49425 tert-butyl 4-[(tert-butylamino)carbonyl]-1-piperazinecarboxylate C14H27N3O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

Ethyl nipecotate (I) was protected as the N-Boc derivative (II) and subsequently reduced to alcohol (III) by means of LiAlH4. Conversion of alcohol (III) into iodide (IV) was achieved by treatment with iodine and triphenylphosphine. The dianion of the chiral azetidinecarboxylic acid (V) was alkylated with iodide (IV) to furnish adduct (VI) as a diastereomeric mixture that was desilylated to (VII) using tetrabutylammonium fluoride. Benzyl ester (VIII) was then obtained by reaction of carboxylic acid (VII) with benzyl bromide and NaHCO3.

1 Treuner, U.; Kronenthal, D.R.; Xu, Z.; Seiler, S.; Slusarchyk, W.A.; Bisacchi, G.; Randazzo, M.E.; Sutton, J.C.; Shi, Z.; Zahler, R.; Schwinden, M.D. (Bristol-Myers Squibb Co.); Amidino and guanidino azetidinone tryptase inhibitors. WO 9967215 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25693 ethyl 3-piperidinecarboxylate 5006-62-2 C8H15NO2 详情 详情
(II) 26186 1-(tert-butyl) 3-ethyl 1,3-piperidinedicarboxylate C13H23NO4 详情 详情
(III) 51124 tert-butyl 3-(hydroxymethyl)-1-piperidinecarboxylate C11H21NO3 详情 详情
(IV) 51120 tert-butyl 3-(iodomethyl)-1-piperidinecarboxylate C11H20INO2 详情 详情
(V) 51121 (2S,3R)-3-[[1-(tert-butoxycarbonyl)-3-piperidinyl]methyl]-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid C21H38N2O5Si 详情 详情
(VI) 49426 (2S)-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid C10H19NO3Si 详情 详情
(VII) 51122 (2S,3R)-3-[[1-(tert-butoxycarbonyl)-3-piperidinyl]methyl]-4-oxo-2-azetidinecarboxylic acid C15H24N2O5 详情 详情
(VIII) 51123 tert-butyl 3-([(2S,3R)-2-[(benzyloxy)carbonyl]-4-oxoazetidinyl]methyl)-1-piperidinecarboxylate C22H30N2O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(IX)

The homochiral azetidinone (IX) was prepared from the known beta-lactam (VIII) by N-silylation with tert-butyldimethylsilyl chloride followed by catalytic hydrogenolysis of the benzyl ester. The 3-silylated azetidinone intermediate (X) was obtained by treatment of the lithium enolate of (IX) with trimethylsilyl chloride. Subsequent Peterson reaction of (X) with the 4-silyloxybenzaldehyde (XI) and LDA furnished olefin (XII) as a mixture of geometric isomers. After esterification of the carboxylate group of (XII) with benzyl alcohol in the presence of EDC to yield (XIII), the catalytic hydrogenation of the olefin double bond of (XIII) gave rise to the cis-azetidinone (XIV). The N-tert-butyldimethylsilyl group of (XIV) was selectively removed by treatment with HF in acetonitrile to afford (XV). Acylation of the lactam N of (XV) with acid chloride (VII) in the presence of sodium hexamethyldisilazide provided (XVI). The remaining silyl group of (XVI) was finally removed by treatment with ammonium hydrogen difluoride in NMP-DMF.

1 Adlington, R.M.; Baldwin, J.E.; Becker, G.W.; et al.; Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen. J Med Chem 2001, 44, 10, 1491.
2 Chen, B.; Adlington, R.M.; Baldwin, J.E.; et al.; Design and synthesis of novel monocyclic beta-lactam inhibitors of prostate specific antigen. Bioorg Med Chem Lett 1997, 7, 13, 1689.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIIa) 50935 (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(Z)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylic acid C33H41NO4Si2 详情 详情
(XIIb) 50936 (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(E)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylic acid C33H41NO4Si2 详情 详情
(XIIIa) 50937 benzyl (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(Z)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylate C40H47NO4Si2 详情 详情
(XIIIb) 50938 benzyl (2S)-1-[tert-butyl(dimethyl)silyl]-3-[(E)-(4-[[tert-butyl(diphenyl)silyl]oxy]phenyl)methylidene]-4-oxo-2-azetidinecarboxylate C40H47NO4Si2 详情 详情
(VII) 50932 benzyl 3-(2-chloro-2-oxoethyl)benzoate C16H13ClO3 详情 详情
(VIII) 50942 (S)-Benzyl 2-azetidinone-4-carboxylate; Benzyl (S)-4-oxo-2-azetidinecarboxylate 72776-05-7 C11H11NO3 详情 详情
(IX) 49426 (2S)-1-[tert-butyl(dimethyl)silyl]-4-oxo-2-azetidinecarboxylic acid C10H19NO3Si 详情 详情
(X) 50933 lithium (2R)-1-[tert-butyl(dimethyl)silyl]-4-oxo-3-(trimethylsilyl)-2-azetidinecarboxylate C13H26LiNO3Si2 详情 详情
(XI) 50934 4-[[tert-butyl(diphenyl)silyl]oxy]benzaldehyde C23H24O2Si 详情 详情
(XIV) 50939 benzyl (2S,3S)-1-[tert-butyl(dimethyl)silyl]-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate C40H49NO4Si2 详情 详情
(XV) 50940 benzyl (2S,3S)-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate C34H35NO4Si 详情 详情
(XVI) 50941 benzyl (2S,3S)-1-(2-[3-[(benzyloxy)carbonyl]phenyl]acetyl)-3-(4-[[tert-butyl(diphenyl)silyl]oxy]benzyl)-4-oxo-2-azetidinecarboxylate C50H47NO7Si 详情 详情
Extended Information